Haemonetics CorporationHAENYSE
Loading
EBITDA Margin Over TimeStrong
Percentile Rank100
3Y CAGR+9.7%
5Y CAGR+6.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+9.7%/yr
vs +2.0%/yr prior
5Y CAGR
+6.1%/yr
Recent acceleration
Acceleration
+7.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM28.48%+8.9%
202526.16%+15.9%
202422.57%+4.7%
202321.56%+11.7%
202219.30%-8.9%
202121.18%-18.8%
202026.09%+30.8%
201919.94%+17.8%
201816.93%+21.7%
201713.91%-